Researchers demonstrate use of gold nanoparticles for cancer detection

June 03, 2005

Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, say medical researchers from the University of California, San Francisco and Georgia Institute of Technology.

The researchers are a father and son, working together on opposite coasts. Their study findings are reported in a recent edition (May 11) of the journal Nano Letters, published by the American Chemical Society.

Principal author is Ivan El-Sayed, MD, assistant professor of otolaryngology at UCSF Medical Center, who conducted the study with his father, Mostafa El-Sayed, PhD, director of the Laser Dynamics Laboratory and chemistry professor at Georgia Tech.

"Gold nanoparticles are very good at scattering and absorbing light," said Mostafa. "We wanted to see if we could harness that scattering property in a living cell to make cancer detection easier. So far, the results are extremely promising."

Many cancer cells have a protein, known as epidermal growth factor receptor (EFGR), all over their surface, while healthy cells typically do not express the protein as strongly. By conjugating, or binding, the gold nanoparticles to an antibody for EFGR, suitably named anti-EFGR, the researchers were able to get the nanoparticles to attach themselves to the cancer cells.

"After we added the nanoparticle-bound antibody to cells, using a simple technique known as darkfield microscopy, we saw the cancer cells light up under the microscope," said Ivan. "The healthy cells don't bind the particles well and are dark compared to the cancer. Since the particles have color, we can test multiple antibodies at the same time with a white light. Using simple optics, we can develop low cost techniques for rapid automated detection of cancer in biopsies. Further, we hope to use the scattering and absorption properties to develop techniques to detect cancer in humans without a biopsy."

In the study, the research team found that the gold nanoparticles have 600 percent greater affinity for cancer cells than for noncancerous cells. The researchers tested their technique using cell cultures of two different types of oral cancer and one nonmalignant cell line. They found two features of the particles to be useful for cancer detection. First, with a microscope, they could see the cells shining. Second, they could measure changes in the amount of light absorbed by the particle as the antibody bound to its target.

According to Ivan, the changes in absorption may be particularly useful in cancer and cell research to measure molecules interacting inside living cells. The change in the absorption spectrum of the gold nanoparticles is also found to distinguish between cancer cells and noncancerous cells. Since nanoparticles of different shapes and sizes absorb and scatter light differently, multiple color probes can be made which may detect many molecules at the same time.

What makes this technique so promising, the researchers explained, is that it doesn't require expensive high-powered microscopes or lasers to view the results, as other techniques require. All it takes is a relatively simple, inexpensive microscope and white light.

Another benefit is that the results are instantaneous. "If you take cells from a cancer stricken tissue and spray them with these gold nanoparticles that have this antibody, you can see the results immediately. The scattering is so strong that you can detect a single particle," said Mostafa.

Finally, the technique isn't toxic to human cells. A similar technique using artificial atoms known as quantum dots uses semiconductor crystals to mark cancer cells, but the semiconductor material is potentially toxic to the cells and humans.

"The wonderful thing about colloidal gold is that it has been used in humans for 50 years," Ivan said. "For example, a radioactive form of it has been used to search for cancer and we know how it is handled by the body."

"This technique is very simple and inexpensive to use," said Ivan. "We think it holds great promise in making cancer detection in humans and under the microscope easier, faster and less expensive."

While the technique is not ready to be used in patients, Ivan said it holds much promise for oral cancer patients he treats in his practice at UCSF Medical Center. "Oral cancer is deadly and tends to recur. Our best chance to save lives is to catch it early, and this method might allow that." He added that this technique could be used to detect a number of cancers, including stomach, colon and skin cancers.

"Our findings also have strong implications for this technique's value to cancer research," Ivan added. "By watching the particle change colors in living cells we can identify molecular interactions within the cells. This may help us unravel the inner workings of a cancer cell and produce better treatments. The fact that we can see one particle is exciting."
-end-
The research was supported by a grant from the Chemical Science, Geoscience and Biosciences Division of the U.S. Department of Energy.

University of California - San Francisco

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.